US 10768167
Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer
granted A61KA61K2039/505
Quick answer
US patent 10768167 (Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer) held by UNIVERSITÄTSKLINIKUM REGENSBURG expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- UNIVERSITÄTSKLINIKUM REGENSBURG
- Grant date
- Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/505